ClaveSuan Desarrollos Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.21M
Latest Deal Amount
  • Investors
  • 2

ClaveSuan Desarrollos General Information

Description

Developer of medical product designed for organ transplantation. The company's products are used in the clinical development of cardiotrophin-1 for the transplant of solid organs, enabling healthcare institutions to provide patients better care at an affordable range.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare
Drug Discovery
Primary Office
  • Calle Emilio Arrieta
  • 11 Bis 2º
  • 31002 Pamplona
  • Spain
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ClaveSuan Desarrollos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 06-Feb-2008 $2.21M 00.000 Completed Startup
To view ClaveSuan Desarrollos’s complete valuation and funding history, request access »

ClaveSuan Desarrollos Board Members (1)

Name Representing Role Since
Teodoro Leon Cillero Self Board Member 000 0000
To view ClaveSuan Desarrollos’s complete board members history, request access »

ClaveSuan Desarrollos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Clave Venture Capital Minority 000 0000 000000 0
Suanfarma Biotech Venture Capital Minority 000 0000 000000 0
To view ClaveSuan Desarrollos’s complete investors history, request access »